
New Contacts Let You See Infrared Light—Even with Your Eyes Closed
Humans have a new way of seeing infrared light, without the need for clunky night-vision goggles. Researchers have made the first contact lenses to convey infrared vision — and the devices work even when people have their eyes closed.
The team behind the invention, led by scientists at the University of Science and Technology of China (USTC) in Hefei, gave the lenses their power by infusing them with nanoparticles that convert near-infrared light in the 800–1,600-nanometre range into shorter-wavelength, visible light that humans can see, in the 400–700-nanometre range. The researchers estimate that the lenses cost around US$200 per pair to make.
The technology, which was detailed in Cell on 22 May, 'is incredibly cool, just like something out of a science-fiction movie', says Xiaomin Li, a chemist at Fudan University in Shanghai, China. It opens up 'new possibilities for understanding the world around us', he adds.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Pros and cons
Near-infrared light sits just outside the range of wavelengths that humans can normally detect. Some animals can sense infrared light, although probably not well enough to form images.
Night-vision goggles enable humans to see infrared radiation, but they are bulky and require a power source to work. The new lenses avoid these limitations while also offering richer, multi-coloured infrared images that night-vision goggles, which operate on a monochrome green scale, typically do not.
However, the lenses do have their own shortcomings. Because the embedded nanoparticles scatter light, the images the lenses create are blurry. The team partially corrected this by putting the technology into glasses with additional lenses that redirect the light. Moreover, unlike night-vision goggles, which amplify light to detect low-level infrared signals, the lenses allow users to see only intense infrared signals, such as those emitted by light-emitting diodes (LEDs).
For these reasons, some critics don't think the lenses will prove useful. 'I cannot think of any application that would not be fundamentally simpler with infrared goggles,' says Glen Jeffery, a neuroscientist at University College London who specializes in eye health. 'Evolution has avoided this for a good reason.'
Nevertheless, the authors think that their lenses can be further optimized and foresee several possible uses for the invention. For instance, wearers would be able to read anti-counterfeit marks that emit infrared wavelengths but are otherwise invisible to the human eye, says co-author Yuqian Ma, a neuroscientist at the USTC.
Li, who was not involved in the work, offers another possibility: the lenses might be worn by doctors conducting near-infrared fluorescence surgery, to directly detect and remove cancerous lesions 'without relying on bulky traditional equipment'.
'An exhilarating moment'
To create the contact lenses, the scientists built on previous research in which they gave mice infrared vision by injecting nanoparticles into the animals' retinas. This time, they took a less invasive approach and added nanoparticles made of rare-earth metals including ytterbium and erbium to a soup of polymer building blocks to form the soft lenses, and then tested them for safety.
The main challenge, Ma says, was to pack enough nanoparticles into the lenses to convert sufficient infrared light into detectable visible light, while not otherwise altering the lenses' optical properties, including their transparency.
Tests in mice showed that animals wearing the lenses tended to choose a dark box that was considered 'safe' over one lit up by infrared light, whereas mice without the lenses showed no preference for either box. Humans wearing the lenses could see flickering infrared light from an LED well enough to both pick up Morse code signals and sense which direction the signals were coming from. The lenses' performance even improved when participants closed their eyes, because near-infrared light easily penetrates the eyelids, whereas visible light, which could have interfered with image formation, does so to a lesser degree.
'Witnessing people wearing contact lenses and successfully seeing infrared flashes was undoubtedly an exhilarating moment,' Ma says.
The team now plans to find ways to cram more nanoparticles into the lenses and hopes to develop particles that can convert light with higher efficiency, to improve the technology's sensitivity. 'We have overcome the physiological limitations of human vision, as if opening a brand-new window onto the world,' Ma says.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Carey International Group (CIG) and SYMX Energy Announce Start of Construction of CIG's Utility-scale Solar Portfolio
ORLANDO, Fla., June 3, 2025 /PRNewswire/ -- Carey International Group ("CIG"), a diversified holding company focused on growing North American assets in the energy/renewables, commercial real estate, and financial services, increased its size of its energy-asset specific construction financial commitments to $870 million for its CIG energy platform company's projects. With the start of construction, SYMX Energy Corp., a wholly owned subsidiary of SYMX Holdings Corporation, a global industry-leading EPC, is on track to begin delivering fields in 2026, providing affordable electricity to US customers. This commitment reinforces SYMX's ability to deliver infrastructure and energy-related projects. "Our execution of these projects with the Carey International Group ("CIG") reflects SYMX's strategic focus on growing our U.S. renewable energy platform," added Andrew Ramos, President and CEO of SYMX. "We are extremely proud of our teams, whose expertise and dedication continue to drive SYMX's successful expansion across the United States in response to the consistently strong demand for renewable energy. In addition, our construction commitments are a significant milestone accomplishment for our pipeline of energy projects and our partnership with CIG Companies." Christopher Kane, CIG's Chief Investment Officer, stated, "Today's announcement is a major step towards the realization of delivering cost-effective electricity to the ERCOT marketplace. Utility-scale solar is still the lowest levelized cost of production when compared to other forms of generation. It will continue to be an efficient way to supply our grids and power the megatrends of artificial intelligence, data center growth, and industrial reshoring in the United States. With the formal start of construction, we intend to deliver utility-scale solar assets starting in the summer of 2026." About Carey International Group (CIG) Headquartered in Orlando, FL, Carey International Group (CIG) is a diversified holding company focused on growing North American assets in the energy/renewables, commercial real estate, and financial services sectors. Current portfolio companies include CIG Companies, CIG Renewables, CIG Capital, Magnifica, and Magnifica Air. Realized portfolio assets include franchise finance, direct lending, and capital markets intermediary services. CIG's current pipeline of projects includes more than 3 GW of utility-scale solar projects, a US-based manufacturer of solar modules, and various hospitality and residential projects across North America. For more information, please visit or About SYMX Established in 1999, SYMX, through its related fourteen subsidiaries, has evolved alongside its world-renowned Strategic Partners into a fully integrated turnkey resource on a global scale in engineering, development, financing, construction and management and operations of highly complex projects ranging from energy, infrastructure, healthcare and life sciences and renewable energy worldwide. Our commitment is to continually empower our partners to make informed decisions based on the scope of each project. We help optimize the balance between cost and scope, resulting in efficient design and operational readiness that satisfies our client's objectives to provide high-quality developments and services. SYMX provides innovative technologies, products, and services that help our customers maximize their value throughout the life cycle of an asset and advance a sustainable energy future. Within SYMX, we focus on executing our value proposition: to collaborate and engineer solutions to maximize asset value for our customers. Our value proposition means that both our customers, our partners, and SYMX will benefit as we pursue technology differentiation, digital adoption, and capital efficiency that create value for our customers and all our stakeholders. Contact View original content to download multimedia: SOURCE MHMS Group LLC Sign in to access your portfolio


New York Times
5 hours ago
- New York Times
The Best Red-Light Therapy Device
Connie Park/NYT Wirecutter Connie Park/NYT Wirecutter Connie Park/NYT Wirecutter At first blush, the LightStim for Wrinkles seems devoid of bells and whistles. But it dazzles where it truly matters: in the jam-packedness of its 72 LEDs, its handiness, and its foolproof one-button operating system. Like all wands, though, it requires you to actively engage with it, and it's not cordless. For a handheld device, it's loaded with LEDs. If you're going to put in the time and effort to manually move a wand around, it should cover a good portion of your face. And the LightStim does just that, with 72 LEDs packed into a circle that's just a skosh under 5 square inches. In comparison, the Lumicure Light Therapy Torch has three LEDs in a 0.78-square-inch circle, and while the Solwave 4-in-1's little 0.75-square-inch wand head has 14 (seven dual) LEDs, it requires significantly more elbow grease to equally treat the same amount of skin. Some testers liked that they could simply press the LightStim's large head against their faces until the three-minute timer signaled that they could move it to a different location. This wand emits four different wavelengths of red light. The wavelength is what determines light's color, and these LEDs are amber (605-nanometer wavelength), light red (630 nm), deep red (680 nm), and near infrared (855 nm). The varying wavelengths spark different reactions at various levels of the skin: Amber, red, and infrared penetrate to reduce oil and inflammation, as well as to stimulate collagen and elastin production, which makes skin look plumper and firmer and minimizes the appearance of fine lines. (Since infrared is invisible, the 865 nm LEDs might not appear lit, even when the power is on.) The Solawave 4-in-1, meanwhile, emits a single wavelength, 630 nm. One tester loved the LightStim's range of reds, especially for treating nasolabial folds and other lines around her mouth. The simple design makes it beyond easy to use, and silent. The LightStim is on or off — and that's all there is to it. Every three minutes, a quick tone indicates that it's time for you to move it to a different part of your face or body (unlike most of the devices we tested, this wand has no automatic shutoff). Whereas the Solawave 4-in-1 buzzes and lightly vibrates, the LightStim is dead quiet and inert in the palm, with one tester likening it in vibes and looks to an old-timey candlestick telephone. Testers also appreciated that the wand's single button required zero practice or guesswork. You also operate the Therabody TheraFace and Dr. Dennis Gross DRx Spectralite via on-device push buttons, but those models, both of which are masks, require cycling through many presses to change modes, and while the mask is attached to your face, it's hard to tell which color mode you're in. You can use it on other body parts. Signs of aging aren't limited to the face, and our testers liked using the LightStim on their necks, décolletages, and even scars, as well. Sure, our flexible mask pick, the Omnilux Men, can also be placed on or wrapped around body parts other than the face, but the LightStim was the easiest device to use in this regard. Flaws but not dealbreakers The LightStim can drag a bit against skin unless you use it with a serum. But this was true of all the wands we tried. Our testers found it more comfortable to press the wand head against the skin and hold it there for a bit. It needs to be plugged in. Of the 11 devices we tested, the LightStim is the only one that has a cord. For something you use for about 12 minutes at a time, staying within 6 feet of an outlet isn't such a big deal, and the wand will never conk out mid-treatment (as the rechargeable Solawave 4-in-1 did a few times in our tests). Complicating matters, though, is that the AC/DC adapter detaches from the wand — increasing its chances of being misplaced. The plastic housing feels a bit cheap. Especially when you consider the wand's $250 price tag. Key specs LEDs: 72 Wavelengths: 605 nm, 630 nm, 660 nm, 865 nm Irradiance: 65 mW/cm2 Treatment time: three minutes per area (no automatic shutoff) Charging: none; powered by AC/DC adapter Return policy: 30 days when bought from LightStim Warranty: five years
Yahoo
5 hours ago
- Yahoo
Hewlett Packard Enterprise (NYSE:HPE) Expands Fault-Tolerant Solutions With New Nonstop Compute Offerings
Hewlett Packard Enterprise recently unveiled two new products in its HPE Nonstop Compute lineup, enhancing their capability to support critical operations with high availability. This product launch, along with other enhancements in AI computing and networking, likely added weight to HPE's 3% price increase over the past month, aligning closely with the broader market's performance. While the market saw a 2% increase over the past week and a 12% rise over the past year, HPE's varied technological advancements and compliance features supported its positive movement, countering any other market fluctuations. We've identified 1 possible red flag with Hewlett Packard Enterprise and understanding the impact should be part of your investment process. Find companies with promising cash flow potential yet trading below their fair value. The recent introduction of HPE's new products enhances its capacity to maintain high availability for critical operations. This aligns with HPE's strategic focus on AI and cloud strategies, which are anticipated to drive revenue and margin growth. The enhancements could potentially bolster HPE's competitive edge, further integrating high-margin offerings such as GreenLake into its portfolio. The market has reacted positively to these advancements, reflected in a 3% increase in HPE's share price over the past month. This price movement positions HPE well, considering a consensus price target of US$19.98, which suggests room for future growth from the current share price of US$16.49. Over a five-year span, HPE's total shareholder return, combining share price appreciation and dividends, was 75.96%. Despite underperforming the US Tech industry and broader market over the past year, this long-term gain demonstrates HPE's resilience and ability to deliver consistent returns. Analysts are factoring in both opportunities, such as synergies from the Juniper acquisition and potential AI-driven revenue, and challenges like regulatory and operational risks, which may impact future earnings forecasts. Analysts predict revenue growth of 4.6% per year, which, though slower than the broader market forecast, highlights a steady expansion path for HPE underpinned by its recent product developments. Gain insights into Hewlett Packard Enterprise's outlook and expected performance with our report on the company's earnings estimates. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:HPE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data